Liquidia (LQDA) Total Current Liabilities (2019 - 2026)

Liquidia's (LQDA) quarterly Total Current Liabilities came in at $149.7 million in Q1 2026, up 147.43% year-on-year from $60.5 million in Q1 2025, and up 10.29% quarter-over-quarter from $135.8 million in Q4 2025.

Liquidia (LQDA) Total Current Liabilities (2019 - 2026) Analysis & Trends

Liquidia's Total Current Liabilities history runs 8 years deep, the most recent figure standing at $149.7 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 147.43% year-over-year to $149.7 million in Q1 2026; TTM through Mar 2026 was $149.7 million, a 147.43% increase from a year earlier, with the FY2025 full-year figure at $135.8 million, up 224.95% from the prior year.
  • Total Current Liabilities rose to $149.7 million in Q1 2026 per LQDA's latest filing, from $135.8 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $149.7 million in Q1 2026 and bottomed at $6.8 million in Q1 2023.
  • The 5-year median for Total Current Liabilities is $21.9 million (2024), against an average of $43.4 million.
  • Across the five-year window, Total Current Liabilities slipped 14.49% in 2023 and soared 224.95% in 2025, its largest moves.
  • Year by year, Total Current Liabilities stood at $8.8 million in 2022, then surged by 110.8% to $18.6 million in 2023, then surged by 125.23% to $41.8 million in 2024, then surged by 224.95% to $135.8 million in 2025, then climbed by 10.29% to $149.7 million in 2026.
  • Per Business Quant, the three latest LQDA Total Current Liabilities figures stand at $149.7 million (Q1 2026), $135.8 million (Q4 2025), and $102.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.66 Bn
10 Liquidia 7.84 Bn 7.61 Bn 121.79 Mn 149.74 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 149.74 Mn
Dec 31, 2025 135.77 Mn
Sep 30, 2025 102.94 Mn
Jun 30, 2025 78.41 Mn
Mar 31, 2025 60.52 Mn
Dec 31, 2024 41.78 Mn
Sep 30, 2024 33.84 Mn
Jun 30, 2024 24.22 Mn
Mar 31, 2024 21.93 Mn
Dec 31, 2023 18.55 Mn
Sep 30, 2023 12.16 Mn
Jun 30, 2023 19.50 Mn
Mar 31, 2023 6.82 Mn
Dec 31, 2022 8.80 Mn
Sep 30, 2022 7.46 Mn
Jun 30, 2022 6.84 Mn
Mar 31, 2022 7.98 Mn
Dec 31, 2021 7.33 Mn
Sep 30, 2021 7.06 Mn
Jun 30, 2021 6.97 Mn